TITLE:
Experimental Medication For the Treatment of Generalized Anxiety Disorder

CONDITION:
Anxiety Disorder

INTERVENTION:
experimental anti-anxiety drug

SUMMARY:

      The purpose of this study is to determine whether an experimental anti-anxiety medication is
      effective in the treatment of Generalized Anxiety Disorder.
    

DETAILED DESCRIPTION:

      Protocol 04-001-01

      The primary objective of the study is to assess, under controlled conditions, the safety and
      efficacy of an experimental anti-anxiety medication relative to placebo in subjects with
      generalized anxiety disorder (GAD).

      The secondary objective of the study is to study algorithms for discontinuation of an
      experimental anti-anxiety medication.

      Recruiting: Participants are currently being recruited and enrolled.
    

ELIGIBILITY:
Gender: All
Age: 18 Years to 65 Years
Criteria:

        Inclusion Criteria:

          -  Subjects 18 to 65 years of age will be eligible to participate if they satisfy the
             DSM-IV-TR criteria for the diagnosis of GAD.

        Exclusion Criteria:

          -  No other primary psychiatric diagnosis besides GAD.
      
